Individualized Medication Guidance for Prostate Cancer
Product Quick Detail
- Minimum Order
- 1
- Packaging
- N/A
- Delivery
- 15 Days
Specifications
This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication
reference for prostate cancer patients.
Features of Individualized Medication Guidance for Prostate Cancer Diagnosis Targeted therapy-Including SNV, InDel, CNV and gene rearrangement, comprehensively guide targeted drug use.
Immunotherapy-Detect TMB and MSI indicators, as well as positive and negative immune-related genes, provide information to guide immunosuppressive therapy.
Chemotherapy- Detect chemotherapeutic drug loci associated with prostate cancer, suggesting sensitivity and toxic side effects of chemotherapeutic drugs.
Hereditary risk assessment- Covering HRR pathway genes, suggesting pathogenic and suspected pathogenic variants, guiding PARP inhibitor therapy, and suggesting genetic risk based on family tumor
history and other information.
Applicable Population of Individualized Medication Guidance for Prostate Cancer Prognosis, Prostate Cancer Prevention, Prostate Cancer Therapy
Prostate cancer patients who have relapsed, drug-resistant problem.
Prostate cancer patients who have been diagnosed with prostate cancer, and need liquid biopsy for targeted therapy and immunotherapy.
Late-stage newly diagnosed prostate cancer patients who need targeted therapy and immunotherapy.
If you want to know more details of chemotherapy for prostate cancer, please visit our website.
As an ivd in vitro diagnostic company, we can offer sorts of ivd in vitro diagnostic equipment for sale, if you are interested, please leave us a message.
- Country: China (Mainland)
- Business Type:
- Market:
- Founded Year:
- Address:Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing
- Contact:capitalbio technology
Other products from CapitalBio Technology Co., Ltd.
Relate products of Individualized Medication Guidance for Prostate Cancer
Individualized Medication Guidance for Gynecologic Cancer
Gynecologic Cancer Surgery According to the latest Chinese women\'s new cancer statistics, cervical cancer and ovarian cancer are in the top ten new cases of female cancer (about 110,000 and 60,000 respectively). With the widespread clinical use of poly(ADP-ribose) polymerase ...
Individualized Medication Guidance for Gastrointestinal Cancer
This test detects 84 genes related to gastrointestinal cancer, provides information on targeted drug, chemotherapy, and hereditary risk assessment. Features of Individualized Medication Guidance for Gastrointestinal Cancer Treatment Targeted drug Gastrointestinal targeted drug ...
